Metaanalysis of the efficacy and safety of ampicillin/sulbactam in the treatment of patients with bacterial infections of the lower respiratory tract

Infectious Diseases in Clinical Practice

Volumn 6, Issue 7, 1997, Pages 473-481

  Zervos, Marcus J ^a,c   Skupien, Donna ^a,d   Dmuchowski, Carl F ^b,c  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Biostatistics ^*  (United States)

^c WILLIAM BEAUMONT HOSPITAL   (United States)

^d QUEST Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFAMANDOLE; CEFOTAXIME; CEFOXITIN; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; SULTAMICILLIN;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; CLINICAL TRIAL; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; META ANALYSIS; PNEUMONIA; RASH;

EID: 0030664143     PISSN: 10569103     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019048-199706070-00012     Document Type: Article

References (11)

1. Fine MJ, Smith MA, Carson CA, et al. Prognosis and outcomes of patients with community-acquired pneumonia: a meta-analysis. JAMA 1996;275:134-41.
2. Geckler RW. A comparison of ampicillin/sulbactam and cefuroxime in the treatment of patients with bacterial infections of the lower respiratory tract. Clin Ther 1994; 16:662-72.
3. Jauregui J, Minns P, Hageage G. Ampicillin/sulbactam compared with cefotaxime in the treatment of lower respiratory tract infections of bacterial etiology. Adv Ther 1995,12:62-71.
4. Rossoff LJ, Hilton E, Smith C, et al Intravenous ampicillin, sulbactam versus cefuroxime axetil in the treatment of patients hospitalized with community-acquired lower respiratory tract infections. Curr Ther Res Clin Exp 56:1995; 852-62. [See erratum in the April 1996 issue noting that the study drug was cefuroxime, not cefuroxime axetil.]
5. Castellano MA, Maniatis T. Ampicillin/sulbactam versus cefoxitin in the treatment of lower respiratory tract infections. Infect Med. In press 1997.
6. Williams D, Perri M, Zervos MJ. Randomized comparative trial with ampicillin/sulbactam versus cefamandole in the therapy of community acquired pneumonia. Eur J Clin Microbiol Infect Dis 1994;13:293-8.
7. Berk SL, Musgrave T, Kalbfleisch J, Hatcher E. A comparison of ampicillin-sulbactam with cefamandole in the treatment of bacterial pneumonia in the elderly. Infect Med 1993;10:29-38.
8. Tan J, File TM. A comparison of ampicillin/sulbactam with cefoxitin in the treatment of lower respiratory tract infections of bacterial etiology. Adv Ther 1994;11:11-20.
9. Hedges LV, Olkin I. Statistical methods for meta-analysis. San Diego (CA): Academic Press; 1985.
10. Niederman MS, Bass JB Jr, Campbell GD, et al. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. Am Rev Respir Dis 1993; 148:1418-26.
11. Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases 4th ed. New York: Churchill Livingstone; 1995.